Body mass index

Where the papers sit

21 papers from the last 6 months study body mass index directly · updated from PubMed 10 Oct 2026

• Obesity-Related Disease Risk

  Obesity and body-fat distribution recur as markers of diabetes risk, treatment outcomes and vascular or surgical complications. In youth, BMI normalization is associated with lower progression to type 1 diabetes, while pregnancy glucose and pre-pregnancy BMI jointly predict gestational diabetes. Waist circumference and relative fat mass are tested against BMI for diabetes classification, with metabolic measures often adding information. Cancer, pulmonary embolism and renal disease studies show that BMI effects vary by disease, treatment and life stage.

  9 papers · 42.9%

• Adiposity and Health Risk

  Anthropometric measures are being evaluated as predictors of mortality, multimorbidity, treatment response and adiposity itself. Cox models and restricted cubic splines recur to capture nonlinear risk across BMI and related indices. Metabolic-inflammatory indices such as CTI extend prediction beyond body size in lymphoma and other conditions. DXA comparisons show that BMI can misclassify adiposity, leaving the best measure for healthy aging and clinical risk assessment unresolved.

  5 papers · 23.8%

• Weight and Chronic Health

  BMI and related weight indices are associated with headache, infertility, disabling arthritis and cardiopulmonary function. Vitamin D appears as a possible mediator of headache risk, while waist-based measures are compared with BMI for reproductive outcomes. Higher BMI is examined alongside exercise capacity in chronic coronary syndrome rather than as an isolated risk marker. The largely cross-sectional evidence maps associations, but does not establish a consistent causal or treatment direction.

  4 papers · 19%

• Body Size and Cancer Treatment

  Nutritional status, inflammation and body size are being used to explain variation in cancer treatment response and delivery. Geriatric Nutritional Risk Index and neutrophil-to-lymphocyte ratio provide prognostic context for intensive treatment. BMI is linked to differing responses to anti-PD-1 therapy in colorectal cancer. Radiotherapy studies focus on whether body habitus affects setup accuracy, while the optimal integration of nutritional and inflammatory measures remains open.

  3 papers · 14.3%